机构:[1]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Ophthalmol, Beijing, Peoples R China[2]Chinese Acad Med Sci & Peking Union Med Coll, Key Lab Ocular Fundus Dis, Beijing, Peoples R China[3]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Hematol, Beijing, Peoples R China[4]Capital Med Univ,Beijing Tongren Hosp,Dept Ophthalmol,Beijing,Peoples R China临床科室眼科首都医科大学附属北京同仁医院首都医科大学附属同仁医院眼科(未分亚科)[5]Xuanwu Hosp, Dept Hematol, Beijing, Peoples R China首都医科大学宣武医院
PurposeTo develop diagnostic recommendations for diffuse large B-cell vitreoretinal lymphoma (VRL) in Chinese patients.MethodsRetrospective observational case series. Seventy-three eyes of 40 VRL patients and 8 control patients were analyzed. Eighteen patients from Beijing Tongren Hospital and 46 patients from literature were involved as validations.ResultsDiagnostic methods included (1) typical clinical manifestations; (2) vitreous cytology; (3) immunohistochemical examination of vitreous or choroid/retina; (4) aqueous humor or vitreous cytokine; (5) vitreous cell gene rearrangement; (6) vitreous flow cytometry. If patients meet (1)+(2)+(3), or if they meet (1), and two of (4), (5), (6) are positive, they can be diagnosed as VRL. The sensitivity and specificity values for accurate diagnosis were 0.975 and 1.00. One hundred percent eyes from Beijing Tongren Hospital and 92.7% eyes from literature can be diagnosed.ConclusionWe developed diagnostic recommendations for diffuse large B-cell VRL through vitreous cytology combined with multiple auxiliary examinations.
基金:
National High Level Hospital Clinical Research Funding [No. 2022- PUMCH-C-038 & 2022-PUMCH-D-002].
第一作者机构:[1]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Ophthalmol, Beijing, Peoples R China[2]Chinese Acad Med Sci & Peking Union Med Coll, Key Lab Ocular Fundus Dis, Beijing, Peoples R China
通讯作者:
通讯机构:[1]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Ophthalmol, Beijing, Peoples R China[2]Chinese Acad Med Sci & Peking Union Med Coll, Key Lab Ocular Fundus Dis, Beijing, Peoples R China[3]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Hematol, Beijing, Peoples R China[4]Capital Med Univ,Beijing Tongren Hosp,Dept Ophthalmol,Beijing,Peoples R China[*1]Department of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China[*2]Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China[*3]Department of Ophthalmology,Beijing Tongren Hospital,Capital Medical University,Beijing,China
推荐引用方式(GB/T 7714):
Zhang Xiao,Zhang Yan,Guan Wenxue,et al.Development of Diagnostic Recommendations for Vitreoretinal Lymphoma[J].OCULAR IMMUNOLOGY AND INFLAMMATION.2024,32(7):1142-1149.doi:10.1080/09273948.2023.2173242.
APA:
Zhang, Xiao,Zhang, Yan,Guan, Wenxue,Zou, Dongmei,Zhao, Chan...&Peng, Xiaoyan.(2024).Development of Diagnostic Recommendations for Vitreoretinal Lymphoma.OCULAR IMMUNOLOGY AND INFLAMMATION,32,(7)
MLA:
Zhang, Xiao,et al."Development of Diagnostic Recommendations for Vitreoretinal Lymphoma".OCULAR IMMUNOLOGY AND INFLAMMATION 32..7(2024):1142-1149